We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




International Panel Warns of Growing Microbe Resistance

By HospiMedica staff writers
Posted on 26 Feb 2001
A panel of health experts is concerned that the rate of antimicrobial resistance, especially in intensive care units (ICUs), is increasing much faster than the rate of the development of new drugs to combat infection-causing microbes. More...
The panel convened during the 30th International Educational and Scientific Symposium of the Society of Critical Care Medicine.

According to the panel, some bacteria are now resistant to all the first-line drugs useful in the past, and outbreaks of these organisms, such as Acinetobacter, are occurring in ICUs around the world. Nearly 40% of Streptococcus pneumoniae are resistant to penicillin in parts of Europe, and worldwide 95% of staphylococci are resistant to penicillin.
According to Jean M. Carlet, M.D., co-chair of the symposium, inappropriate use of antimicrobials is a main reason why bacteria develop resistance. Medical experts at the symposium recommended a number of steps that patients, doctors, and hospitals can take to decrease antimicrobial resistance.

These steps include increasing the use of vaccines to prevent infection; correctly identifying an infection in order to prescribe the appropriate antimicrobial; beginning treatment with a broad-based antibiotic and later prescribing one that precisely targets the causative organism; using antimicrobials only when necessary, at the right dose, and for the proper duration; improving hygiene to prevent the spread of infection; and informing patients about the proper use of antimicrobials.

"In ICUs worldwide, bacterial infections are a major cause of death among critically ill patients. But the rise of antimicrobial resistance has markedly limited the number of treatment options available,” said Dr. Julie Gerberding, of the U.S. Centers for Disease Control and Prevention (Atlanta, GA, USA).



Related Links:
Society of Critical Care Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.